|
|
 |
 |
|
|
|
|
• EMEA: CPMP
The Assessment of the Potential for QT Intverval Prolongation by
Non-Cardiovascular Medicinal Products
• FDA:
Guidance for Industry, part 11; Electronic Records; Electronic
Signature - Scope and Application
• ICH:
The Clinical Evaluation of the QT/QTc Interval Prolongation and
Proarrythmic Potential for Non-antiarrythmic Drugs
|
|
|
|
|
|
|
|
|
|
